#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastroenteropancreatic neuroendocrine tumour disease Urethral valves Metastases to central nervous system Granulomatosis with polyangiitis Frostbite Neuroblastoma recurrent Deafness Synovial sarcoma Salivary gland cancer Liver abscess Pustular psoriasis Brain abscess Erdheim-Chester disease Vernal keratoconjunctivitis Hereditary optic atrophy More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Life with Disease Shprintzen-Goldberg syndrome Angelman’s syndrome – Trials in Disease Mitochondrial myopathy – Diagnostics Hereditary angioedema – Trials in Disease Osteosarcoma – Diagnostics Skin angiosarcoma Hyperoxaluria – Diagnostics Hairy cell leukaemia – Diagnostics Progressive supranuclear palsy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Navitoclax Cannabis Sativa Flower IADADEMSTAT Fostemsavir Trometamol Ferumoxytol Brexucabtagene Autoleucel Vinorelbine Lactic Acid Seladelpar Estradiol Hemihydrate Magnesium Proline Paxalisib Follitropin Beta Valbenazine Ditosylate Sasanlimab Human Serum Albumin DAPIGLUTIDE Mk-1084 Gskvx000000008885 More therapies…

    Learn about Your Condition

    Primary hypercholesterolaemia Hand fracture Osteotomy Pharyngeal cancer stage II Post procedural complication Craniocerebral injury Pulmonary tuberculosis Agitation Epidermolysis bullosa Vulvar dysplasia Hypogonadism male Tinnitus Anxiety Gastrointestinal melanoma Hidradenitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effect of Levobupivacaine in Reducing Chronic Pain After Open Inguinal Hernia Repair in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Abdominal pain
    • Abdominal wall pain
    • Hernia repair
    Spain

  • Study on Rituximab for Achieving Remission in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Rituximab
    The Netherlands

  • Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dimethyl Fumarate
    • Diroximel Fumarate
    • Glatiramer Acetate
    France

  • Study on the Effects of Cerebrolysin and Sodium Chloride for Recovery in Patients with Moderate to Severe Traumatic Brain Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Cerebrolysin Concentrate
    • Sodium Chloride
    Romania

  • Study on the Safety and Effects of ION582 for Patients with Angelman Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Angelman’s syndrome
    Investigated Drugs:
    • 2′-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Ube3A Antisense Transcript Rna
    France Italy

  • Study on Amantadine for Reducing Motor Fluctuations in Advanced Parkinson’s Disease Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Amantadine Hydrochloride
    France
Previous Page
1 … 30 31 32 33 34 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!